Brand
Graviti Pharmaceuticals Private Limited
1 federal recall on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Graviti Pharmaceuticals Private Limited and translate it into plain English — free weekly digest, optional same-day alerts.
- 2025-10-29FDA-DrugClass IIBupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.
Failed Tablet/Capsule Specifications
Get notified about new Graviti Pharmaceuticals Private Limited recalls
Free weekly digest. We email when a new federal recall affects Graviti Pharmaceuticals Private Limited or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state